Derivation of a novel multi-gene prognostic model based on regulated cell death pathways in acute myeloid leukemia: A comprehensive bioinformatic analysis integrating gene expression, mutation profiling, and immune infiltration.

<h4>Background</h4>Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy with dismal survival outcomes, where dysregulation of regulated cell death (RCD) pathways plays a pivotal role in leukemogenesis and therapeutic resistance.<h4>Methods</h4>Differenti...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali Ahmadi, Amir Abas Navidinia, Davood Bashash, Behzad Poopak, Shadi Esmaeili
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0328412
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849387742457233408
author Ali Ahmadi
Amir Abas Navidinia
Davood Bashash
Behzad Poopak
Shadi Esmaeili
author_facet Ali Ahmadi
Amir Abas Navidinia
Davood Bashash
Behzad Poopak
Shadi Esmaeili
author_sort Ali Ahmadi
collection DOAJ
description <h4>Background</h4>Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy with dismal survival outcomes, where dysregulation of regulated cell death (RCD) pathways plays a pivotal role in leukemogenesis and therapeutic resistance.<h4>Methods</h4>Differential expression analyses were performed comparing AML samples with healthy bone marrow. Diagnostic differentially expressed genes (DEGs) were then intersected with curated gene sets representing apoptosis, pyroptosis, autophagy, necroptosis, and ferroptosis to derive an RCD-based gene signature. Prognostic markers were identified by univariate Cox regression, and these markers were refined using LASSO regression to construct a multi-gene prognostic model that generated an individual risk score (RS) for each patient. The performance of the model was validated internally through Kaplan-Meier survival analyses and receiver operating characteristic (ROC) curves for 1-, 3-, and 5-year survival, and externally confirmed in an independent TARGET-AML cohort. In addition, mutation analysis was conducted using the maftools package, and immune infiltration profiling was performed with CIBERSORT and xCell to characterize the molecular landscape of the risk groups.<h4>Results</h4>Our integrative approach yielded a four-gene prognostic model incorporating ARHGEF35, GSN, ELANE, and AKT3. High RS was strongly associated with adverse overall survival, with Kaplan-Meier analyses showing p-value < 0.0001 in the training cohort and p-value = 0.0026 in the testing cohort. The model demonstrated robust predictive accuracy with AUC values of 82%, 87%, and 91% for 1-, 3-, and 5-year survival in the training set, and 65%, 81%, and 94% in the testing set. Mutation analysis revealed that DNMT3A and RUNX1 mutations were significantly enriched in high-RS patients (p-value = 0.0015 and p-value = 0.0086, respectively), whereas KIT mutations were more prevalent in low-RS patients (p-value = 0.0058). Immune profiling indicated that high-RS patients had increased M2 macrophage infiltration (p-value = 0.0027) and reduced resting mast cells (p-value = 0.0033).<h4>Conclusion</h4>These findings establish that an RCD-based multi-gene risk model can robustly stratify AML patients by prognosis and illuminate underlying genomic and immunologic mechanisms, thereby offering promising avenues for personalized therapeutic strategies.
format Article
id doaj-art-c59e08a0cc924a2cb1b86023da33a19f
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-c59e08a0cc924a2cb1b86023da33a19f2025-08-20T03:44:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01208e032841210.1371/journal.pone.0328412Derivation of a novel multi-gene prognostic model based on regulated cell death pathways in acute myeloid leukemia: A comprehensive bioinformatic analysis integrating gene expression, mutation profiling, and immune infiltration.Ali AhmadiAmir Abas NavidiniaDavood BashashBehzad PoopakShadi Esmaeili<h4>Background</h4>Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy with dismal survival outcomes, where dysregulation of regulated cell death (RCD) pathways plays a pivotal role in leukemogenesis and therapeutic resistance.<h4>Methods</h4>Differential expression analyses were performed comparing AML samples with healthy bone marrow. Diagnostic differentially expressed genes (DEGs) were then intersected with curated gene sets representing apoptosis, pyroptosis, autophagy, necroptosis, and ferroptosis to derive an RCD-based gene signature. Prognostic markers were identified by univariate Cox regression, and these markers were refined using LASSO regression to construct a multi-gene prognostic model that generated an individual risk score (RS) for each patient. The performance of the model was validated internally through Kaplan-Meier survival analyses and receiver operating characteristic (ROC) curves for 1-, 3-, and 5-year survival, and externally confirmed in an independent TARGET-AML cohort. In addition, mutation analysis was conducted using the maftools package, and immune infiltration profiling was performed with CIBERSORT and xCell to characterize the molecular landscape of the risk groups.<h4>Results</h4>Our integrative approach yielded a four-gene prognostic model incorporating ARHGEF35, GSN, ELANE, and AKT3. High RS was strongly associated with adverse overall survival, with Kaplan-Meier analyses showing p-value < 0.0001 in the training cohort and p-value = 0.0026 in the testing cohort. The model demonstrated robust predictive accuracy with AUC values of 82%, 87%, and 91% for 1-, 3-, and 5-year survival in the training set, and 65%, 81%, and 94% in the testing set. Mutation analysis revealed that DNMT3A and RUNX1 mutations were significantly enriched in high-RS patients (p-value = 0.0015 and p-value = 0.0086, respectively), whereas KIT mutations were more prevalent in low-RS patients (p-value = 0.0058). Immune profiling indicated that high-RS patients had increased M2 macrophage infiltration (p-value = 0.0027) and reduced resting mast cells (p-value = 0.0033).<h4>Conclusion</h4>These findings establish that an RCD-based multi-gene risk model can robustly stratify AML patients by prognosis and illuminate underlying genomic and immunologic mechanisms, thereby offering promising avenues for personalized therapeutic strategies.https://doi.org/10.1371/journal.pone.0328412
spellingShingle Ali Ahmadi
Amir Abas Navidinia
Davood Bashash
Behzad Poopak
Shadi Esmaeili
Derivation of a novel multi-gene prognostic model based on regulated cell death pathways in acute myeloid leukemia: A comprehensive bioinformatic analysis integrating gene expression, mutation profiling, and immune infiltration.
PLoS ONE
title Derivation of a novel multi-gene prognostic model based on regulated cell death pathways in acute myeloid leukemia: A comprehensive bioinformatic analysis integrating gene expression, mutation profiling, and immune infiltration.
title_full Derivation of a novel multi-gene prognostic model based on regulated cell death pathways in acute myeloid leukemia: A comprehensive bioinformatic analysis integrating gene expression, mutation profiling, and immune infiltration.
title_fullStr Derivation of a novel multi-gene prognostic model based on regulated cell death pathways in acute myeloid leukemia: A comprehensive bioinformatic analysis integrating gene expression, mutation profiling, and immune infiltration.
title_full_unstemmed Derivation of a novel multi-gene prognostic model based on regulated cell death pathways in acute myeloid leukemia: A comprehensive bioinformatic analysis integrating gene expression, mutation profiling, and immune infiltration.
title_short Derivation of a novel multi-gene prognostic model based on regulated cell death pathways in acute myeloid leukemia: A comprehensive bioinformatic analysis integrating gene expression, mutation profiling, and immune infiltration.
title_sort derivation of a novel multi gene prognostic model based on regulated cell death pathways in acute myeloid leukemia a comprehensive bioinformatic analysis integrating gene expression mutation profiling and immune infiltration
url https://doi.org/10.1371/journal.pone.0328412
work_keys_str_mv AT aliahmadi derivationofanovelmultigeneprognosticmodelbasedonregulatedcelldeathpathwaysinacutemyeloidleukemiaacomprehensivebioinformaticanalysisintegratinggeneexpressionmutationprofilingandimmuneinfiltration
AT amirabasnavidinia derivationofanovelmultigeneprognosticmodelbasedonregulatedcelldeathpathwaysinacutemyeloidleukemiaacomprehensivebioinformaticanalysisintegratinggeneexpressionmutationprofilingandimmuneinfiltration
AT davoodbashash derivationofanovelmultigeneprognosticmodelbasedonregulatedcelldeathpathwaysinacutemyeloidleukemiaacomprehensivebioinformaticanalysisintegratinggeneexpressionmutationprofilingandimmuneinfiltration
AT behzadpoopak derivationofanovelmultigeneprognosticmodelbasedonregulatedcelldeathpathwaysinacutemyeloidleukemiaacomprehensivebioinformaticanalysisintegratinggeneexpressionmutationprofilingandimmuneinfiltration
AT shadiesmaeili derivationofanovelmultigeneprognosticmodelbasedonregulatedcelldeathpathwaysinacutemyeloidleukemiaacomprehensivebioinformaticanalysisintegratinggeneexpressionmutationprofilingandimmuneinfiltration